Acumed, the globally recognized leader in orthopaedic and medical solutions, is thrilled to announce the successful closing of a $25 million funding round aimed at further advancing its mission to improve patient care worldwide. Founded in 1988 by Mary and Randy Huebner in Butler, NJ, Acumed has evolved from a small family business into a multi-award-winning organization headquartered in Hillsboro, Oregon. With an impressive legacy that began with contract work for implant prototypes, the company has rapidly expanded its portfolio since launching its first line of arthroscopy screws for ACL ligaments in 1991. This newly acquired funding will be pivotal in facilitating the research, design, and manufacturing of innovative medical devices to meet the growing needs of healthcare professionals and patients alike. Acumed is dedicated to maintaining the highest standards of quality, with over 90% of its implants produced domestically, and this investment will enhance its capabilities in this area. With a strong global distribution network and a commitment to excellence, Acumed continues to be at the forefront of the industry. The funds will primarily be allocated to the development of new product lines and enhancement of existing technologies that improve surgical outcomes and patient recovery times. By investing in state-of-the-art manufacturing equipment and research initiatives, Acumed aims to uphold its founders' vision while ensuring that it remains a trusted partner within the healthcare community. This funding marks an exciting new chapter for Acumed, as it continues to push the boundaries of innovation in orthopaedic solutions.







